Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF | NRIFD

Nuvo Research, Inc. is a Canadian specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units: the Topical Products and Technology (TPT) Group (formerly the Pain Group) and the Immunology Group.
Price: $6.30 | Change: +$0.04 | %Change: +0.64%
Volume: 29,062 | Day High/Low: 6.50/6.25 | 52 Week High/Low: 8.33/1.85
View modes: 
1 star

Nasdaq Easily Qualified

Wall Street beckons us.  rate and reply
5 stars

RE:RE:RE:RE:RE:RE:Mega Deal

Google Nasdaq CAPITAL MARKET requirements. Nuvo easily meets those at this point.  rate and reply
0 stars

And another thing Buddy

Remember the answer my girl friend gave me? Yah Remember what I said? Yah Well it's coming true Buddy Odds are really not a gamble at all If you think then so shall it be Do you have any more life...read more
5 stars

Hey Buddy it just goes to show you things can change

We used to be invested in a Dog. Now it's much different. We have a Van. All we need now is a bottle to pizz in. Good thinking.  rate and reply
0 stars

RE:RE:RE:RE:RE:Mega Deal

I read through the various criteria and scenarios to get a Nasdq listing and I did not see how NUVO could pass any of the 3 sets of criteria for possibly one or two more years. I am interested to...read more
1 star

RE:RE:RE:RE:RE:RE:RE:Mega Deal

Their stock options average $7.54 so if they exercise those , they are well earned and won't cost us much. Total compensation for the 3 quarters of 2014 was less than $3 million. You forget that our...read more
5 stars

Gap Filled

The price gap from April 2012 between $7.47 and $7.80 has been filled leaving $8.45 as the next logical target price for the stock. I am thinking that momentum indicators are going straight up with...read more
5 stars

RE:RE:RE:RE:RE:RE:Mega Deal

Perhaps I should have qualified my post by saying the initial impact would be a 20% increase in the share price - I do not disagree what so ever if the longer term value being significantly higher. I...read more
0 stars

RE:RE:RE:RE:RE:Mega Deal

good luck to chasers, nothing to scoff at, +60% in 2 weeks. :) cheers, dave.  rate and reply
5 stars

RE:RE:RE:RE:RE:Mega Deal

despite the clowns running this show, I would expect a much greater value appreciation than 20% with a Nasdaq listing.  a normal company with the assets and promise that Nuvo has would normally be...read more
2 stars

RE:RE:RE:RE:Mega Deal

Just good value being recognized by investors at large. We shall soon have $7.50 in hard cash and no debt. and great assets besides that including WF10. So, whats the risk. Management is however on a...read more
5 stars

RE:RE:RE:RE:Mega Deal

My WAG is that a NASDAQ listing would add about 20% to the share price. The WF10 story would get maximum play in the US and significantly increase exposure to the company. It would also attract new...read more
0 stars

RE:RE:RE:Mega Deal

Lots of background buzz. Nasdaq listing most probable .  rate and reply
0 stars

RE:WF10

oops strong  rate and reply
0 stars

WF10

There will be an article that states the WF10 group had a lower incident of cancer over the placebo group. Patients is a cup that only the stong can drink from .....  rate and reply
5 stars

RE:RE:RE:Mega Deal

bigzig wrote: Future considerations. wtf are you talking about?  that you traded your brain for "future considerations"?  rate and reply
0 stars

RE:RE:Mega Deal

Future considerations.  rate and reply
3 stars

RE:Mega Deal

yeah, up your endo!  rate and reply
1 star

Mega Deal

Looking good. Endo?  rate and reply
2 stars

RE:rock07's funny math

Actually, my numbers are an under estimate as I forgot to include India and China. The global OTC topical analgesics market is now estimated to be over $4 billion versus less than $800 million in the...read more